Schedule 13D ownership disclosure

LAVA THERAPEUTICS NV

Security class unavailable · CUSIP: N51517105

Event date: 2022-09-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-256665
Form type
SC 13D/A
Filer
LAVA Therapeutics NV
CIK
CIK 1840748
Filed
Oct 03, 2022
Reporting period
Sep 27, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub